PCM
UTHR icon

Polaris Capital Management’s United Therapeutics UTHR Stock Holding History

Polaris Capital Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$29M Sell
53,450
-43,200
-45% -$24.3M 2.73% 9
2026
Q1 		$57.3M Sell
96,650
-7,000
-7% -$3.49M 4.69% 4
2025
Q4 		$50.5M Sell
103,650
-18,400
-15% -$8.57M 4.19% 5
2025
Q3 		$51.2M Sell
122,050
-5,600
-4% -$1.88M 3.36% 6
2025
Q2 		$36.7M Sell
127,650
-9,400
-7% -$2.81M 2.44% 10
2025
Q1 		$42.2M Buy
137,050
+5,200
+4% +$1.78M 2.42% 9
2024
Q4 		$46.5M Sell
131,850
-10,100
-7% -$3.71M 2.24% 9
2024
Q3 		$50.9M Sell
141,950
-6,600
-4% -$2.23M 2.51% 8
2024
Q2 		$47.3M Buy
148,550
+18,600
+14% +$4.92M 2.54% 6
2024
Q1 		$29.9M Sell
129,950
-12,600
-9% -$2.84M 1.49% 35
2023
Q4 		$31.3M Buy
142,550
+8,000
+6% +$1.84M 1.51% 34
2023
Q3 		$30.4M Sell
134,550
-58,600
-30% -$13.5M 1.64% 32
2023
Q2 		$42.6M Sell
193,150
-1,000
-0.5% -$222K 1.6% 32
2023
Q1 		$43.5M Sell
194,150
-127,250
-40% -$31.4M 1.62% 33
2022
Q4 		$89.4M Sell
321,400
-20,500
-6% -$5.18M 3.11% 6
2022
Q3 		$71.6M Sell
341,900
-9,300
-3% -$2.08M 2.81% 6
2022
Q2 		$82.8M Sell
351,200
-3,000
-0.8% -$610K 2.96% 6
2022
Q1 		$63.5M Sell
354,200
-20,600
-5% -$3.92M 2.02% 12
2021
Q4 		$81M Sell
374,800
-6,100
-2% -$1.2M 2.61% 7
2021
Q3 		$70.3M Sell
380,900
-1,200
-0.3% -$236K 2.24% 14
2021
Q2 		$68.6M Buy
382,100
+1,600
+0.4% +$305K 2.21% 12
2021
Q1 		$72.2M Buy
+380,500
New +$63.4M 2.37% 10

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Polaris Capital Management's UTHR Position: Q2 2026 in Review

Polaris Capital Management reduced its United Therapeutics (UTHR) stake by 45% in Q2 2026, selling an estimated $24.3M and leaving 53,450 shares worth $29M. The position accounts for 2.73% of the portfolio, ranked #9.

Polaris Capital Management first reported a position in UTHR in Q1 2021 and has held it in 22 quarters since. The position peaked at $89.4M in Q4 2022. 880 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Polaris Capital Management held 53,450 shares of United Therapeutics worth $29M as of Q2 2026.
  • Polaris Capital Management sold 43,200 United Therapeutics shares in Q2 2026, an estimated $24.3M.
  • United Therapeutics made up 2.73% of Polaris Capital Management's portfolio in Q2 2026, its #9 holding.
  • Polaris Capital Management first reported a position in United Therapeutics in Q1 2021 and has held it in 22 quarters since.
  • Polaris Capital Management's United Therapeutics position peaked at $89.4M in Q4 2022.
  • 880 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Polaris Capital Management's 13F filing for Q2 2026, filed 27 Jul 2026.